Werfen receives CE mark for Aptiva Antiphospholipid Syndrome reagents
New Aptiva® APS IgG and APS IgM reagents enable early diagnosis of Antiphospholipid Syndrome in hard-to-diagnose autoimmune disease
New Aptiva® APS IgG and APS IgM reagents enable early diagnosis of Antiphospholipid Syndrome in hard-to-diagnose autoimmune disease
Immunology expert, Dr. Anna Majowicz, shares how Spark Therapeutics research is helping tackle immunogenicity challenges in AAV-mediated gene therapy
David Wells, CEO of the IBMS, discusses the Institute’s plans to ensure the future of biomedical science careers
New study finds that persistent COVID-19 infections are surprisingly common, with around one to three in every 100 infections lasting a month or longer
Leveraging Quanterix’s Simoa platform, researchers lay the groundwork for pre-symptomatic Alzheimers diagnosis, guided treatment, and accelerated clinical drug trials
Examine the benefits and logistics of transitioning your program from traditional site-based blood collection to remote sampling
The collaboration aims to impact the evolution and enhancement of immunoassay solutions in India
Dr. Julienne Carstens highlights the critical role of spatial biology in understanding the metastatic progression of PDAC and advancing personalized immunotherapy
In this guest editorial, discover how Capitainer® DBS cards with qDBS technology enable easy self-sampling with precision and accuracy
Learn how researchers at KU Leuven are using spectral flow cytometry to investigate how the intestinal nervous and immune systems interact in health and disease states
The new assay allows for the quantitative measurement of Tau phosphorylated
With the QIAGEN nanoplate-based dPCR system, clinical scientists find better ways to diagnose invasive fungal disease and side-step antifungal therapy resistance
Experts discuss the game-changing potential of novel host response-based diagnostics to combat the global challenge of antimicrobial resistance (AMR)
Jiseon Kim, Senior Scientist at ProGen, explores the transformative potential of a bispecific antibody-based drug to lay the foundation for improved healthcare quality
Portable testing platforms are set to drive precision medicine and community health into 2024, so when will they see a more widespread adoption amongst healthcare providers and individuals alike?
Discover how researchers at Weill Cornell Medical College are using immunoproteomics to identify biomarkers that help better understand and manage diabetic infections
The brand-new SelectScience T-shirts and EXCLUSIVE festive sweater are here, find out how you could win one
Discover how a rapid diagnosis between viral and bacterial pulmonary infections can minimize antibiotic usage in critical care
Discover how a smartphone-based diagnostic platform is democratizing point-of-care testing away from the clinic into a home testing setting
The partnership aims to enable single cell workflow automation
Study confirms ALZmetrix whole blood test can detect people at high risk of developing full Alzheimer’s disease
Jeff Jensen, CEO of Fluxion Biosciences, describes how microfluidics technology fuels advances in drug discovery through physiologically relevant cell-based assays
Director of Laboratory Services shares how the right quality control materials can help to improve the accuracy, efficiency, and reliability of patient diagnostics in the clinical lab
Watch this on-demand webinar to learn about an in vitro T cell exhaustion model for the characterization of multi-specific biologics and immunotherapies